Full Breakdown
Challenger Rejects $11.80-per-Share Takeover Bid from TAL Daiichi Life Australia
By Drooid · · How we work
Rejection of the Non-Binding Offer
On 26 October, the board of Challenger (ASX: CGF) formally declined a non-binding acquisition proposal from its largest shareholder, TAL Daiichi Life Australia (TDA). It added that discussions would continue to see whether a recommendable proposal can be reached.
Valuation and Share-Price Context
The rejected bid valued the remaining 79.5 % of Challenger at roughly AU$7.94 billion. Challenger’s shares had traded at $11.92 on 23 October, slightly above the offer price. Bloomberg Intelligence analyst Matt Ingram noted that Challenger’s sum-of-the-parts valuation exceeds the bid, suggesting a revised price of A$12.50-A$13 per share might be more agreeable. As of the end of March, Challenger managed about AU$128 billion in assets and is Australia’s largest annuities provider.
Official Statement from Challenger
Challenger’s statement emphasized uncertainty about any binding offer:
“There is no certainty that the proposal will result in a binding offer or that any transaction will eventuate. Challenger shareholders do not need to take any action at this time,” — the company
The company also reaffirmed that it “highly values” TDA as its largest shareholder and commercial partner, while urging shareholders that no immediate action is required.
Market Reaction and Recent Activity
Following the rejection announcement, Challenger’s shares tracked lower on the ASX on 26 October. Earlier in the year, Challenger completed a merger of its multi-affiliate boutique business Fidante with Channel Capital, creating a platform that positions Channel Group among Australia’s largest investment-services firms.
Background on the Parties
Challenger is an Australian investment-management and financial-services firm established in 1985. TAL Daiichi Life Australia, a unit of Japan’s Daiichi Life Group, acquired roughly 20.5 % of Challenger’s ordinary shares in 2025 and has been pursuing the remaining stake. Japanese insurers have been active overseas as domestic demographic trends limit growth at home.